 |
Friday, September 17, 2004
Gift of the MAGI
By Pat French
Nina Cannon, Manager, Contracts Management, will be speaking later
this month at the leading conference for clinical research contracts
professionals: Contracting & Negotiating Clinical Trials.
Cannon’s talk is titled “The Other Agreements: Confidentiality,
Master, Materials Transfer, Data Use, and More,” and she will
be copresenting it with Stacy S. Switzer, Counsel for Takeda Pharmaceuticals
North America. As the agenda
states, “Confidentiality, master, and other agreements are
not the poor relations of clinical trial agreements. The wise clinical
research contract specialist knows when to use them and how to negotiate
them.”
This twice-yearly international meeting, now in its 14th year,
has until now been sponsored by the Strategic Research Institute
(SRI), a for-profit
group that creates, produces, and manages conferences covering industry
specific business-to-business topics.
This year, however, the meeting is being jointly sponsored by SRI
and by the Model Agreement Group Initiative (MAGI),
a nonprofit group of more than 170 volunteer professionals from
various entities involved in clinical research (including several
from the DCRI). Formed in the fall of 2003, MAGI’s objective
is to develop model agreements that can be used as standards within
the industry, thus reducing the complexity, ambiguity, and length
of negotiations of clinical research contracts.
Also a first for the conference, MAGI will be administering the
new Clinical Research Contract Professional (CRCP) certification
examination, which represents the first standardized credential
for contracts professionals in the clinical research field.
The conference will also feature speakers who are senior decision-makers
from sponsors, contract research organizations (CROs), site management
organizations (SMOs), investigational sites, and academia. Topics
to be discussed include major contract terms and implications; sponsor
and site priorities; cost considerations; negotiating skills; negotiating
budgets and payment terms; partnering to reduce study costs; model,
master, and other ancillary agreements; and managing relationships.
|
 |